The future of antibody drug discovery: From target validation to candidate selection

This webinar will provide an overview of the antibody discovery process highlighting the critical steps involved in developing effective antibody-based therapeutics.
In this webinar, you will learn how Benchling’s Antibody Solution Accelerator can support:
  • Target Identification: The crucial step of identifying and validating specific molecular targets that play a role in disease pathogenesis.

  • Lead Selection: Criteria and assays used to assess factors such as binding affinity, specificity, stability, and pharmacokinetic properties to choose the most suitable leads for further development.

  • In Vivo Safety & Efficacy: Assessing the performance of the antibody in mice and other model organisms.

  • And more!

Watch now

Featured speakers

Sanjay Saraf
Product Manager, Studies at Benchling
Vega Shah, PhD
Senior Product Marketing Manager, Benchling at Benchling

See Benchling in action

Helix Image